Cargando…

Clinical Value of Tissue Transglutaminase Antibodies in Celiac Patients over a Long Term Follow-Up

Introduction & Aim: Anti-tissue transglutaminase antibody (tTGA) titer is used during the follow-up of celiac patients to evaluate gluten-free diet (GFD) responsiveness. However, no clear data are available on this issue. The aim of this study was to evaluate tTGA significance during celiac dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farina, Elisa, Roncoroni, Leda, Lombardo, Vincenza, Scricciolo, Alice, Vecchi, Maurizio, Doneda, Luisa, Elli, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465060/ https://www.ncbi.nlm.nih.gov/pubmed/34578935 http://dx.doi.org/10.3390/nu13093057

Ejemplares similares

Refractory celiac disease and COVID-19 outbreak: Findings from a high incidence scenario in Northern Italy
por: Elli, Luca, et al.
Publicado: (2020)

A Retrospective Study on Dietary FODMAP Intake in Celiac Patients Following a Gluten-Free Diet
por: Roncoroni, Leda, et al.
Publicado: (2018)

Exposure to Different Amounts of Dietary Gluten in Patients with Non-Celiac Gluten Sensitivity (NCGS): An Exploratory Study
por: Roncoroni, Leda, et al.
Publicado: (2019)

Evaluation of a Single Determination of Gluten Immunogenic Peptides in Urine from Unaware Celiac Patients to Monitor Gluten-Free Diet Adherence
por: Lombardo, Vincenza, et al.
Publicado: (2023)

Impact of FODMAP Content Restrictions on the Quality of Diet for Patients with Celiac Disease on a Gluten-Free Diet
por: Bascuñán, Karla A., et al.
Publicado: (2019)

Sucrosomial Iron Supplementation in Anemic Patients with Celiac Disease Not Tolerating Oral Ferrous Sulfate: A Prospective Study
por: Elli, Luca, et al.
Publicado: (2018)

How to manage celiac disease and gluten-free diet during the COVID-19 era: proposals from a tertiary referral center in a high-incidence scenario
por: Elli, Luca, et al.
Publicado: (2020)

Correction to: How to manage celiac disease and gluten-free diet during the COVID-19 era: proposals from a tertiary referral center in a high-incidence scenario
por: Elli, Luca, et al.
Publicado: (2022)

Efficacy of a High-Iron Dietary Intervention in Women with Celiac Disease and Iron Deficiency without Anemia: A Clinical Trial
por: Scricciolo, Alice, et al.
Publicado: (2020)

Vaccination Status and Attitudes towards Vaccines in a Cohort of Patients with Celiac Disease
por: Costantino, Andrea, et al.
Publicado: (2022)

Fr006 IMPACT OF A SARS-COV2 INFECTION IN PATIENTS WITH CELIAC DISEASE
por: Elli, Luca, et al.
Publicado: (2021)

Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area
por: Elli, Luca, et al.
Publicado: (2022)

Safety of occasional ingestion of gluten in patients with celiac disease: a real-life study
por: Elli, Luca, et al.
Publicado: (2020)

COVID-19 Vaccine: A Survey of Hesitancy in Patients with Celiac Disease
por: Costantino, Andrea, et al.
Publicado: (2021)

Oxidative stress as a biomarker for monitoring treated celiac disease
por: Moretti, Sarah, et al.
Publicado: (2018)

Nutritional and Gastroenterological Monitoring of Patients With Celiac Disease During COVID-19 Pandemic: The Emerging Role of Telemedicine and Point-of-Care Gluten Detection Tests
por: Costantino, Andrea, et al.
Publicado: (2021)

Mediterranean Gluten-Free Diet: Is It a Fair Bet for the Treatment of Gluten-Related Disorders?
por: Bascuñán, Karla A., et al.
Publicado: (2020)

Circulating microRNAs Suggest Networks Associated with Biological Functions in Aggressive Refractory Type 2 Celiac Disease
por: Bianchi, Nicoletta, et al.
Publicado: (2022)

A Low FODMAP Gluten-Free Diet Improves Functional Gastrointestinal Disorders and Overall Mental Health of Celiac Disease Patients: A Randomized Controlled Trial
por: Roncoroni, Leda, et al.
Publicado: (2018)

Correction: Roncoroni, L. et al. A Low FODMAP Gluten-Free Diet Improves Functional Gastrointestinal Disorders and Overall Mental Health of Celiac Disease Patients: A Randomized Controlled Trial. Nutrients 2018, 10, 1023
por: Roncoroni, Leda, et al.
Publicado: (2019)

Nutrition in Patients with Inflammatory Bowel Diseases: A Narrative Review
por: Roncoroni, Leda, et al.
Publicado: (2022)

Extracellular matrix proteins and displacement of cultured fibroblasts from duodenal biopsies in celiac patients and controls
por: Roncoroni, Leda, et al.
Publicado: (2013)

Are Treated Celiac Patients at Risk for Mycotoxins? An Italian Case-Study
por: Cirlini, Martina, et al.
Publicado: (2016)

Isolation and culture of fibroblasts from endoscopic duodenal biopsies of celiac patients
por: Roncoroni, Leda, et al.
Publicado: (2009)

Diagnostic management of patients reporting symptoms after wheat ingestion
por: Costantino, Andrea, et al.
Publicado: (2022)

Fr100 TELEMEDICINE IN GASTROENTEROLOGY: A STUDY ON FEASIBILITY AND PATIENTS’ TRUST DURING COVID-19 PANDEMIC.
por: Costantino, Andrea, et al.
Publicado: (2021)

Heavy Metal and Rice in Gluten-Free Diets: Are They a Risk?
por: Bascuñán, Karla A., et al.
Publicado: (2023)

Increased Mercury Levels in Patients with Celiac Disease following a Gluten-Free Regimen
por: Elli, Luca, et al.
Publicado: (2015)

AF.27 COVID-19 VACCINE: A SURVEY ON HESITANCY IN PATIENTS WITH CELIAC DISEASE
por: Costantino, A., et al.
Publicado: (2021)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)

Mucosal tissue transglutaminase expression in celiac disease
por: Villanacci, Vincenzo, et al.
Publicado: (2009)

Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
por: Vader, L. Willemijn, et al.
Publicado: (2002)

Adherence to dietary treatment and clinical factors associated with anti-transglutaminase antibodies in celiac disease during the follow-up
por: Miró, Marta, et al.
Publicado: (2021)

B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2
por: du Pré, M. Fleur, et al.
Publicado: (2019)

Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease
por: Kaunisto, Helka, et al.
Publicado: (2022)

Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe?
por: Iervasi, Erika, et al.
Publicado: (2023)

The Production of the Oral Mucosa of Antiendomysial and Anti—Tissue-Transglutaminase Antibodies in Patients with Celiac Disease: A Review
por: Compilato, Domenico, et al.
Publicado: (2010)

Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease
por: Torsten, Matthias, et al.
Publicado: (2018)

Microbial transglutaminase should be considered as an environmental inducer of celiac disease
por: Lerner, Aaron, et al.
Publicado: (2019)

Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease
por: Hawamdeh, Hasan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pckgmq4ek4jlsqdh9pt1q5epkj